Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fibrinolysis; its mechanism and significance.

Literature DB >> 18884682

Fibrinolysis; its mechanism and significance.

R G MACFARLANE, R BIGGS.

Abstract

Keywords: FIBRINOLYSIS

Mesh：
Fibrinolysis
Humans

Year: 1948 PMID： 18884682

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. [Hyperfibrinolysis in prostatic carcinoma].

Authors: J BREDT
Journal: Blut Date: 1962-03

2. [Studies on fibrinolysis of experimental coagulation thrombi by thrombo-stop].

Authors: W SANDRITTER; H HERMANN
Journal: Klin Wochenschr Date: 1955-09-01

3. [Determination of the profibrinolysin time].

Authors: S WITTE; P DIRNBERGER
Journal: Klin Wochenschr Date: 1954-02-01

4. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors: Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal: Breast Care (Basel) Date: 2008-10-15 Impact factor: 2.860

Review 5. Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid.

Authors: Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Michael P Chapman; Kirk C Hansen; Angela Sauaia; Christopher C Silliman; Anirban Banerjee
Journal: J Trauma Acute Care Surg Date: 2015-06 Impact factor: 3.313

6. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.

Authors: Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal: Transfusion Date: 2016-04 Impact factor: 3.157

Fibrinolysis; its mechanism and significance.

1. [Hyperfibrinolysis in prostatic carcinoma].

2. [Studies on fibrinolysis of experimental coagulation thrombi by thrombo-stop].

3. [Determination of the profibrinolysin time].

4. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Review 5. Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid.

6. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.

Review 7. [Problems associated with transfusion of post mortem blood].

8. [Comparative thrombelastographic study on citrated sternal marrow blood and venous blood].

9. [Changes in blood coagulation in pulmonary surgery].

10. The occurrence of fibrin in the lungs in an autopsy material.